Carmona-Abellan M, Del Pino R, Murueta-Goyena A, Acera M, Tijero B, Berganzo K, Gabilondo I, Gómez-Esteban J C
Neurodegenerative Diseases Division, Health Research Institute Biocruces, Barakaldo, Bizkaia, Spain.
Neurodegenerative Diseases Division, Health Research Institute Biocruces, Barakaldo, Bizkaia, Spain.
Neurologia (Engl Ed). 2021 May 26. doi: 10.1016/j.nrl.2021.04.007.
Multiple system atrophy is a rare and fatal neurodegenerative disorder, characterized by autonomic dysfunction in association with either parkinsonism or cerebellar signs. The pathologic hallmark is the presence of alpha-synuclein aggregates in oligodendrocytes, forming glial cytoplasmic inclusions. Clinically, it may be difficult to distinguish form other parkinsonisms or ataxias, particularly in the early stages of the disease. In this case series we aim to describe in detail the features of MSA patients.
Unified MSA Rating Scale (UMSARS) score, structural and functional imaging and cardiovascular autonomic testing, are summarized since early stages of the disease.
UMSARS proved to be useful to perform a follow-up being longitudinal examination essential to stratify risk of poor outcome. Neuropathological diagnosis showed an overlap between parkinsonian and cerebellar subtypes, with some peculiarities that could help to distinguish from other subtypes.
A better description of MSA features with standardized test confirmed by means of neuropathological studies could help to increase sensitivity.
多系统萎缩是一种罕见的致命性神经退行性疾病,其特征为自主神经功能障碍,并伴有帕金森综合征或小脑体征。病理标志是少突胶质细胞中存在α-突触核蛋白聚集体,形成胶质细胞质内含物。临床上,尤其是在疾病早期,可能难以将其与其他帕金森综合征或共济失调区分开来。在本病例系列中,我们旨在详细描述多系统萎缩患者的特征。
自疾病早期起,总结统一多系统萎缩评定量表(UMSARS)评分、结构和功能影像学以及心血管自主神经测试情况。
UMSARS被证明有助于进行随访,纵向检查对于分层不良预后风险至关重要。神经病理学诊断显示帕金森型和小脑型亚型之间存在重叠,有一些特殊之处有助于与其他亚型区分开来。
通过神经病理学研究证实的标准化测试对多系统萎缩特征进行更好的描述,有助于提高敏感性。